Iron medicine plus standard therapy for advanced stomach cancer
Treatments studied
Part of Cancer clinical trials.
This Phase 3 study tests whether giving ferric carboxymaltose (an IV iron treatment) helps people with advanced stomach or stomach–esophagus cancer and iron-deficiency anemia. The goal is to improve safety and how well the standard first-line cancer treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 19 or older
- Your cancer is advanced (cannot be removed) or has spread, and it is confirmed as stomach or stomach–esophagus adenocarcinoma
- You have iron-deficiency anemia (low hemoglobin around 8 to under 11, plus low iron stores by specific blood tests)
- You have not had palliative chemo medicines yet for advanced/recurrent stomach or GEJ cancer, and you are planning first-line treatment with fluoropyrimidine plus platinum (with possible targeted therapy or immunotherapy)
- You can likely stay in the study for at least 24 weeks and you are not severely ill (performance status 0 to 2)
- You meet major safety checks: weight 35 kg or more and kidney/liver function and infections are not too severe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of iron given through a vein to treat anemia (low red blood cells) after surgery for stomach cancer. It aims to find which treatment is more effective at improving your blood count and energy levels.
This Phase 3 study tests whether giving iron (as ferric carboxymaltose) after complex major surgery can improve recovery by helping your body rebuild blood and oxygen levels after blood loss. It may help patients who are having certain types of aortic, liver, or pancreas operations.
This Phase 3 study tests whether giving a specific iron medicine before major gynecologic cancer surgery can improve recovery. It’s mainly for people with low blood counts from low iron stores before surgery.
This trial tests whether giving iron through a vein can help people with colorectal cancer who have low iron stores but are not anemic. It looks at patients scheduled for curative colon or rectum surgery.
This trial tests whether giving iron through a vein before surgery helps people with stomach (gastric) cancer who need an operation. It may be aimed at improving iron levels around the time of gastrectomy (stomach removal).
This trial tests whether getting iron through an IV can help prevent or treat anemia in people with ovarian cancer. It aims to see if this can improve energy and quality of life during treatment.
Hear when a new Advanced Gastric Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.